A randomized, outcome assessor blinded, parallel- arm, single center investigator initiated trial to evaluate the efficacy and safety of electroacupuncture stimulator on mild cognitive impairment

Dongshin University0 个研究点目标入组 36 人开始时间: 待定最近更新: 2020年3月23日

适应症

试验速览

暂无简介。

•Participants meeting all of the following criteria will be included in this trial. The inclusion criteria are as follows: 1) participants(males and females) aged 55 to 85 ; 2) participants who meet the Peterson diagnostic criteria for MCI, with memory impairments for at least 3 months; 3) Score in K-MMSE was 20-23; 4) Score in MoCA-K was 0-22;5) fluency in language sufficient to reliably complete all study assessment; 6) voluntarily signed the informed consent form.

•Participants with a poor general condition and those who are not fit for electroacupuncture will be excluded. The exclusion criteria are as follows: 1) diagnosed with dementia according to the Diagnostic and Statistical Manual of Mental Disorders- ?; 2) history of brain structure lesions which may cause cognitive impairment(e.g., traumatic brain injury, stroke, intracranial space-occupying lesions, congenital mental retardation); 3) complicated by cancer and serious diseases of the cardiovascular, cerobrovascular, liver, and kidney; 4) who had been treated with alcohol or drug dependency, mental diseases(e.g., schizophrenia, serious anxiety, and depression) in the past six months in the past six months; 5) Currently under treatment for MCI(e.g., medication, acupuncture, and cognitive training); 6) who have difficulties in assessment due to visual and hearing impairments; 7) who are not fit for electroacupuncture (e.g., blood clotting abnormalitiessuch as hemophilia, infection of the head skin, and pacemaker attached); 8) concurrent participation in other clinical trials

发起方